This company has been marked as potentially delisted and may not be actively trading. VPC Impact Acquisition (VIH) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock VIH vs. ENFN, SEMR, SCWX, LGTY, CTV, XPER, MIXT, IDN, ICLK, and MAQCShould you be buying VPC Impact Acquisition stock or one of its competitors? The main competitors of VPC Impact Acquisition include Enfusion (ENFN), Semrush (SEMR), SecureWorks (SCWX), Logility Supply Chain Solutions (LGTY), Innovid (CTV), Xperi (XPER), MiX Telematics (MIXT), Intellicheck (IDN), iClick Interactive Asia Group (ICLK), and Maquia Capital Acquisition (MAQC). VPC Impact Acquisition vs. Its Competitors Enfusion Semrush SecureWorks Logility Supply Chain Solutions Innovid Xperi MiX Telematics Intellicheck iClick Interactive Asia Group Maquia Capital Acquisition Enfusion (NYSE:ENFN) and VPC Impact Acquisition (NASDAQ:VIH) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends. Is ENFN or VIH more profitable? Enfusion has a net margin of 1.70% compared to VPC Impact Acquisition's net margin of 0.00%. Enfusion's return on equity of 6.67% beat VPC Impact Acquisition's return on equity.Company Net Margins Return on Equity Return on Assets Enfusion1.70% 6.67% 4.86% VPC Impact Acquisition N/A N/A N/A Which has preferable valuation and earnings, ENFN or VIH? Enfusion has higher revenue and earnings than VPC Impact Acquisition. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnfusion$201.61M6.94$6.03M$0.03361.63VPC Impact AcquisitionN/AN/A-$4.86MN/AN/A Do analysts recommend ENFN or VIH? Enfusion currently has a consensus price target of $12.25, suggesting a potential upside of 12.91%. Given Enfusion's stronger consensus rating and higher possible upside, research analysts clearly believe Enfusion is more favorable than VPC Impact Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Enfusion 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33VPC Impact Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders hold more shares of ENFN or VIH? 81.1% of Enfusion shares are owned by institutional investors. Comparatively, 52.5% of VPC Impact Acquisition shares are owned by institutional investors. 36.4% of Enfusion shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media favor ENFN or VIH? In the previous week, VPC Impact Acquisition's average media sentiment score of 0.87 beat Enfusion's score of 0.00 indicating that VPC Impact Acquisition is being referred to more favorably in the news media. Company Overall Sentiment Enfusion Neutral VPC Impact Acquisition Positive SummaryEnfusion beats VPC Impact Acquisition on 10 of the 11 factors compared between the two stocks. Get VPC Impact Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for VIH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VIH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VIH vs. The Competition Export to ExcelMetricVPC Impact AcquisitionPrepackaged Software IndustryComputer SectorNASDAQ ExchangeMarket Cap$504.18M$6.03B$27.76B$9.11BDividend YieldN/A1.62%3.11%4.02%P/E RatioN/A154.3136.8320.25Price / SalesN/A4.461,883.2599.61Price / CashN/A54.7538.1558.16Price / Book24.624.257.275.49Net Income-$4.86M$50.49M$767.31M$250.27M VPC Impact Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VIHVPC Impact AcquisitionN/A$19.45-6.6%N/A+11.7%$504.18MN/A0.003ENFNEnfusionN/A$10.85+0.5%$12.25+12.9%+24.7%$1.40B$201.61M271.29890High Trading VolumeSEMRSemrush3.5635 of 5 stars$9.05+0.0%$16.43+81.5%-36.7%$1.34B$396.02M113.191,170SCWXSecureWorksN/A$8.51flat$7.00-17.7%N/A$755.94M$365.88M-8.602,350LGTYLogility Supply Chain SolutionsN/A$14.29+0.1%N/AN/A$481.42M$101.87M-1,429.00324High Trading VolumeCTVInnovid0.0756 of 5 stars$3.14flat$2.75-12.4%N/A$466.21M$151.56M-34.892,280XPERXperi2.7277 of 5 stars$8.10+2.4%$19.00+134.7%-5.4%$368.51M$488.88M-4.262,100MIXTMiX TelematicsN/A$14.55flatN/AN/A$353.75M$150.06M58.201,080IDNIntellicheck3.0751 of 5 stars$5.17-4.1%$5.83+12.8%+52.5%$102.60M$20.21M-172.3350High Trading VolumeICLKiClick Interactive Asia GroupN/A$9.43+12.3%N/A+550.3%$95.63M$130.44M0.001,190Gap UpHigh Trading VolumeMAQCMaquia Capital AcquisitionN/A$11.30flatN/AN/A$58.99MN/A0.004 Related Companies and Tools Related Companies Enfusion Alternatives Semrush Alternatives SecureWorks Alternatives Logility Supply Chain Solutions Alternatives Innovid Alternatives Xperi Alternatives MiX Telematics Alternatives Intellicheck Alternatives iClick Interactive Asia Group Alternatives Maquia Capital Acquisition Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VIH) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VPC Impact Acquisition Holdings Please log in to your account or sign up in order to add this asset to your watchlist. Share VPC Impact Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VIH Stock Alerts